Godrej Agrovet Crosses ₹10,000 Crore Revenue in FY26, Posts Record Profit

Why It Matters

The results underscore Godrej Agrovet’s expanding footprint in India’s high‑growth agribusiness sector and highlight divergent segment dynamics that will shape future investment and strategic focus.

Key Takeaways

• Revenue topped ₹10,233 crore ($1.23 bn), up 9.1% YoY.
• Oil palm profit jumped 68% to ₹384 crore ($46 m).
• Animal nutrition volumes rose 12%, profit up 19.3%.
• Crop care profit fell 27% amid weather and regulatory issues.
• Net working capital days fell to 25, boosting ROCE to 20%.

Pulse Analysis

India’s agribusiness landscape is consolidating around a few diversified players, and Godrej Agrovet’s FY26 performance cements its status as a market leader. The company’s revenue breakthrough—over ₹10,000 crore, roughly $1.23 billion—reflects robust demand for animal‑feed and oil‑palm products, sectors that benefit from rising rural incomes and government push for domestic oilseed production. By converting key financials into U.S. dollars, investors can more easily benchmark the firm against global agritech peers, noting that a 9% top‑line growth outpaces many regional competitors.

Segment analysis reveals a stark contrast. Oil‑palm profit surged 68% to ₹384 crore ($46 m) thanks to higher palm‑kernel oil prices and improved extraction yields, while animal nutrition delivered 12% volume growth and a 19.3% profit rise, driven by an 18% jump in cattle‑feed sales. Conversely, the crop‑care division suffered a 27% profit drop amid adverse weather, reduced acreage, and regulatory hurdles, and Creamline Dairy’s EBITDA fell 33% as milk procurement costs rose. Astec LifeSciences turned around, approaching EBITDA breakeven after a loss‑making prior year, signaling potential upside in specialty chemicals.

Financially, the firm improved operational efficiency, shrinking net working‑capital days from 39 to 25 and lifting return on capital employed to 20% from 16%. Margins remained stable at 9.1% despite higher input costs, and a one‑time land‑sale gain boosted Q4 PAT by 54.7% to ₹102 crore ($12 m). These metrics suggest a resilient balance sheet capable of weathering sector volatility, positioning Godrej Agrovet for continued expansion and making it an attractive prospect for investors seeking exposure to India’s growing food‑security value chain.